Terms: = Pancreatic cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Prognosis
16 results:
1. Systemic therapy with or without transcatheter intra-arterial therapies for unresectable hepatocellular carcinoma: a real-world, multi-center study.
Pan Y; Zhu X; Liu J; Zhong J; Zhang W; Shen S; Jin R; Liu H; Ye F; Hu K; Xu D; Zhang Y; Chen Z; Xing B; Zhou L; Chen Y; Zeng Y; Liang X; Kuang M; Song T; Xiang B; Wang K; Sun H; Xu L;
Front Immunol; 2023; 14():1138355. PubMed ID: 37180173
[TBL] [Abstract] [Full Text] [Related]
2. [The clinical value of classification of hilar cholangiocarcinoma based on actual anatomy].
Peng SY; Liu YB; Li XS; Wu Y; Jin YQ; Yu XA; Wang W; Gong W
Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):860-865. PubMed ID: 36058713
[No Abstract] [Full Text] [Related]
3. Prognostic value of inflammation-immunity-nutrition score in patients with hepatocellular carcinoma treated with anti-PD-1 therapy.
Zhang Z; Liang Y; Zhong D; Dai Z; Shang J; Lai C; Zou H; Yao Y; Feng T; Huang X
J Clin Lab Anal; 2022 May; 36(5):e24336. PubMed ID: 35312116
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma.
Li B; Shen S; You S; Zhang G; Gao S; Shi X; Wang H; Yin X; Xu X; Guo S; Jin G
BMC Cancer; 2021 May; 21(1):612. PubMed ID: 34034684
[TBL] [Abstract] [Full Text] [Related]
5. YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of runx1-induced transcriptional activation of Warburg effect.
Hou Y; Zhang Q; Pang W; Hou L; Liang Y; Han X; Luo X; Wang P; Zhang X; Li L; Meng X
Cell Death Differ; 2021 Nov; 28(11):3105-3124. PubMed ID: 34021267
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of radiotherapy impact on survival in resected stage I/II pancreatic cancer patients: a population-based study.
Han D; Gao F; Liu JL; Wang H; Fu Q; Yang GW
BMC Cancer; 2021 May; 21(1):560. PubMed ID: 34001035
[TBL] [Abstract] [Full Text] [Related]
7.
Ye H; Li T; Wang H; Wu J; Yi C; Shi J; Wang P; Song C; Dai L; Jiang G; Huang Y; Yu Y; Li J
Front Immunol; 2021; 12():649551. PubMed ID: 33815409
[TBL] [Abstract] [Full Text] [Related]
8. Integration of transcriptome and cistrome analysis identifies runx1-target genes involved in pancreatic cancer proliferation.
Liu S; Xie F; Gan L; Peng T; Xu X; Guo S; Fu W; Wang Y; Ouyang Y; Yang J; Wang X; Zheng Y; Zhang J; Wang H
Genomics; 2020 Nov; 112(6):5343-5355. PubMed ID: 33189780
[TBL] [Abstract] [Full Text] [Related]
9. Nomogram for Estimating Overall Survival in Patients With Metastatic pancreatic cancer.
Goldstein D; Von Hoff DD; Chiorean EG; Reni M; Tabernero J; Ramanathan RK; Botteman M; Aly A; Margunato-Debay S; Lu B; Louis CU; McGovern D; Lee CK
Pancreas; 2020 Jul; 49(6):744-750. PubMed ID: 32541630
[TBL] [Abstract] [Full Text] [Related]
10. The lncRNA runx1-IT1 regulates C-FOS transcription by interacting with runx1 in the process of pancreatic cancer proliferation, migration and invasion.
Liu S; Zhang J; Yin L; Wang X; Zheng Y; Zhang Y; Gu J; Yang L; Yang J; Zheng P; Jiang Y; Shuai L; Cai X; Wang H
Cell Death Dis; 2020 Jun; 11(6):412. PubMed ID: 32487998
[TBL] [Abstract] [Full Text] [Related]
11. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.
Saad AM; Turk T; Al-Husseini MJ; Abdel-Rahman O
BMC Cancer; 2018 Jun; 18(1):688. PubMed ID: 29940910
[TBL] [Abstract] [Full Text] [Related]
12. Augmented expression of runx1 deregulates the global gene expression of U87 glioblastoma multiforme cells and inhibits tumor growth in mice.
Bogoch Y; Friedlander-Malik G; Lupu L; Bondar E; Zohar N; Langier S; Ram Z; Nachmany I; Klausner JM; Pencovich N
Tumour Biol; 2017 Apr; 39(4):1010428317698357. PubMed ID: 28443460
[TBL] [Abstract] [Full Text] [Related]
13. Meta analysis of the association of cholesterol with pancreatic carcinoma risk.
Chen X; Zhou T; Chen M
J BUON; 2015; 20(1):109-13. PubMed ID: 25778304
[TBL] [Abstract] [Full Text] [Related]
14. nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: long-term survival from a phase III trial.
Goldstein D; El-Maraghi RH; Hammel P; Heinemann V; Kunzmann V; Sastre J; Scheithauer W; Siena S; Tabernero J; Teixeira L; Tortora G; Van Laethem JL; Young R; Penenberg DN; Lu B; Romano A; Von Hoff DD
J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25638248
[TBL] [Abstract] [Full Text] [Related]
15. The consumption of omega-3 polyunsaturated fatty acids improves clinical outcomes and prognosis in pancreatic cancer patients: a systematic evaluation.
Ma YJ; Yu J; Xiao J; Cao BW
Nutr Cancer; 2015; 67(1):112-8. PubMed ID: 25425246
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.
Elebro J; Heby M; Gaber A; Nodin B; Jonsson L; Fristedt R; Uhlén M; Jirström K; Eberhard J
J Transl Med; 2014 Oct; 12():289. PubMed ID: 25323550
[TBL] [Abstract] [Full Text] [Related]
